Statistics for Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
Total visits
| views | |
|---|---|
| Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema | 35 |
Total visits per month
| views | |
|---|---|
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
Top country views
| views | |
|---|---|
| United States | 18 |
| Portugal | 8 |
| Canada | 2 |
| China | 2 |
| United Arab Emirates | 1 |
| Finland | 1 |
| United Kingdom | 1 |
| Jordan | 1 |